home All News open_in_new Full Article

Bayer will sich Kapitalerhöhung von Aktionären absegnen lassen

Pharma - Bayer erwägt eine Kapitalerhöhung und will sich diese von seinen Aktionären genehmigen lassen.


today 4 w. ago attach_file Other

attach_file Events
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Society
attach_file Other
attach_file Politics
attach_file Technology
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Other
attach_file Other


ID: 463808238
Add Watch Country

arrow_drop_down